コンテンツへスキップ
Merck
  • Embryological, clinical and ultrastructural study of human oocytes presenting indented zona pellucida.

Embryological, clinical and ultrastructural study of human oocytes presenting indented zona pellucida.

Zygote (Cambridge, England) (2013-09-03)
M Sousa, J Teixeira da Silva, J Silva, M Cunha, P Viana, E Oliveira, R Sá, C Soares, C Oliveira, A Barros
要旨

Human oocyte dysmorphisms attain a large proportion of retrieved oocytes from assisted reproductive technology (ART) treatment cycles. Extracytoplasmic defects involve abnormal morphology of the zona pellucida (ZP), perivitelline space and first polar body. The aim of the present study was to describe a novel dysmorphism affecting the ZP, indented ZP. We also evaluated the clinical, embryological and ultrastructural features of these cases. We evaluated all ART treatment cycles during 7 consecutive years and found 13 treatment cycles (six patients) with all oocytes presenting an indented ZP. In addition, these oocytes presented total or partial absence of the perivitelline space, absence of resistance to ZP and oolemma penetration during microinjection, and low ooplasm viscosity during aspiration. This novel described dysmorphism was recurrent and attained all oocytes in three cases that had more than one treatment cycle. When compared with controls, data showed significant low oocyte maturity (42% versus 81.6%) and high cycle cancellation (30.8% versus 8.5%) rates, normal degeneration (3.4% versus 6.3%) and fertilization rates (69% versus 69.5%), and low pregnancy (15.4% versus 33.3%) and live-birth delivery (7.7% versus 27.7%) rates per cycle. Ultrastructure analysis revealed a zona pellucida structure with large empty electrolucent regions, an outer ZP layer with an indented surface with protuberances and a thick inner ZP that obliterated the perivitelline space. There was evidence of exocytosis of ZP material by the oocyte. In conclusion, oocytes with this novel described dysmorphism (indented ZP) are associated with low maturity, pregnancy and live-birth delivery rates.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
エチルアルコール(純粋), for molecular biology
Sigma-Aldrich
エタノール, JIS special grade, ≥99.5%
Sigma-Aldrich
四酸化オスミウム, ReagentPlus®, 99.8%
Sigma-Aldrich
四酸化オスミウム 溶液, 4 wt. % in H2O
Sigma-Aldrich
プロゲステロン, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
(±)-Propylene oxide, ReagentPlus®, ≥99%
Sigma-Aldrich
エタノール, SAJ first grade, ≥99.5%
Sigma-Aldrich
四酸化オスミウム 溶液, suitable for electron microscopy, 4% in H2O
Sigma-Aldrich
(±)-Propylene oxide, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
四酸化オスミウム 溶液, 2.5 wt. % in tert-butanol
Sigma-Aldrich
エストラジオール, meets USP testing specifications
Sigma-Aldrich
エチルアルコール(純粋), 190 proof, ACS spectrophotometric grade, 95.0%
Sigma-Aldrich
エタノール, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Sigma-Aldrich
四酸化オスミウム, ACS reagent, ≥98.0%
Supelco
エタノール 溶液, certified reference material, 2000 μg/mL in methanol
Sigma-Aldrich
エタノール, puriss. p.a., absolute, ≥99.8% (GC)
Sigma-Aldrich
四酸化オスミウム 溶液, suitable for electron microscopy, 2% in H2O
Sigma-Aldrich
プロゲステロン, meets USP testing specifications
Sigma-Aldrich
グルタルアルデヒド 溶液, Grade I, 25% in H2O, specially purified for use as an electron microscopy fixative
USP
β-エストラジオール, United States Pharmacopeia (USP) Reference Standard
Supelco
エタノール標準品10% (v/v), 10 % (v/v) in H2O, analytical standard
Sigma-Aldrich
グルタルアルデヒド 溶液, 50 wt. % in H2O
Sigma-Aldrich
グルタルアルデヒド 溶液, Grade II, 25% in H2O
Sigma-Aldrich
プロゲステロン, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
エタノール, ≥99.5%, suitable for HPLC
Sigma-Aldrich
Os EnCat® 40, extent of labeling: 0.3 mmol/g Os loading
Sigma-Aldrich
エタノール, JIS special grade, 94.8-95.8%
Sigma-Aldrich
エタノール, ≥99.5%
Sigma-Aldrich
黄体形成ホルモン放出ホルモン, ≥97% (HPLC)
USP
プロゲステロン, United States Pharmacopeia (USP) Reference Standard